COMPLEXES OF ANTIBODIES WITH SOME CYTOKINES Russian patent published in 2005 - IPC

Abstract RU 2263118 C2

FIELD: medicine, oncology, biochemistry.

SUBSTANCE: invention relates to fused proteins, namely to the multifunctional fused protein cytokine-antibody. This fused protein involves immunoglobulin region and cytokine fused protein of the formula IL-12-X or X-IL-12 wherein interleukin-12 (IL-12) represents the first cytokine and X represents the second cytokine taken among the group comprising IL-2, IL-4 and GM-CSF bound covalently either by amino-end or carboxyl-end to subunit p35 or p40 of interleukin-12 (IL-12) in its heterodimeric or a single-chain form. Indicated fused cytokine protein is fused by either its amino-end or carboxyl-end with indicated region of immunoglobulin. Multifunctional fused protein cytokine-antibody shows an anticancer activity.

EFFECT: valuable medicinal properties of protein complexes.

13 cl, 40 dwg, 18 ex

Similar patents RU2263118C2

Title Year Author Number
ENHANCEMENT OF IMMUNE RESPONSE WHEREIN FUSED PROTEIN ANTIBODY-CYTOKINE IS MEDIATOR BY COMBINED TREATMENT WITH AGENTS INCREASING IMMUNOCYTOKINE ABSORPTION 2001
  • Gilliz Stiven D.
  • Lan' Jan'
  • Kholden Sil'Vija A.
RU2272644C2
ENHANCEMENT OF IMMUNE RESPONSES MEDIATED BY PROTEINS FUSED FROM ANTIBODY AND CYTOKINE BY METHOD OF COMBINED ADMINISTRATION OF ANGIOGENESIS INHIBITOR 1999
  • Dzhilliz Stefen D.
RU2229305C2
FUSED PROTEINS WITH IMMUNOGLOBULIN FC-FRAGMENT FOR ENHANCING IMMUNOGENICITY OF PROTEIN AND PEPTIDE ANTIGENS 2000
  • Dzhilliz Stefen D.
  • Lo Kin Ming
  • Vesolovski Dzhon S. Dzhr.
RU2248214C2
ANTI-CANCER TARGETED IMMUNOTHERAPY WITH APPLICATION OF IL-12 2015
  • Shrittmatter Volfgang
  • Khandgretinger Rupert
  • Shilbakh-Shtyukle Karin
RU2689160C2
IL-12 COMPOSITIONS AIMED AT EDB 2019
  • Villa, Alessandra
  • Matasci, Mattia
  • Ongaro, Tiziano
RU2758143C1
HUMANISED ANTIBODY (H14,18) BASED ON MOUSE ANTIBODY 14,18, CONTACTING GD2, AND ITS FUSION WITH IL-2 2003
  • Dzhilliz Stefen D.
  • Lo Kin Ming
RU2366664C2
ISOLATED SOLUBLE IL-20 RECEPTOR (VARIANTS) 2000
  • Foster Donald K.
  • Zu Venfeng
  • Mehdden Kehren L.
  • Kelli Dzhejms D.
  • Spreker Sindi A.
  • Brehndt Kehmeron S.
  • Rikson Mark U.
  • Presnell Skott R.
  • Foks Brajen A.
RU2279441C2
VACCINATION USING THE ALPHA 3 DOMAIN OF MICA/B FOR CANCER TREATMENT 2016
  • Wucherpfennig, Kai
  • Badrinath, Soumya
RU2747296C2
IMMUNOTHERAPY OF MALIGNANT DISEASES OF B-CELLS AND AUTOIMMUNE DISEASES WITH APPLICATION OF CONJUGATE AND NONCONJUGATE ANTIBODIES, COMBINATIONS OF ANTIBODIES AND CONJOINT PROTEINS 2003
  • Goldenberg Dehvid M.
  • Khansen Khans
RU2335297C2
POLYPEPTIDE-LIGAND FLT3 (VARIANTS), POLYNUCLEOTIDE (VARIANTS), EXPRESSING VECTOR (VARIANTS), STRAIN OF CELL CHO (VARIANTS), METHOD FOR PRODUCING POLYPEPTIDE-LIGAND FLT3 (VARIANTS), PHARMACEUTICAL COMPOSITION (VARIANTS) 1994
  • Lajmehn Stjuart D.
  • Bekmann M. Patritsija
RU2220979C2

RU 2 263 118 C2

Authors

Dzhilliz Stefen D.

Lo Kin Ming

Dates

2005-10-27Published

2000-08-09Filed